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Abstract
Sulfur mustard binds to reactive cysteine residues, forming a stable sulfur-hydroxyethylthioethyl 
[S-HETE] adduct that can be used as a long-term biomarker of sulfur mustard exposure in 
humans. The digestion of sulfur mustard-exposed blood samples with proteinase K following total 
protein precipitation with acetone produces the tripeptide biomarker [S-HETE]-Cys-Pro-Phe. The 
adducted tripeptide is purified by solid phase extraction, separated by ultra-high pressure liquid 
chromatography, and detected by isotope dilution tandem mass spectrometry. This approach was 
thoroughly validated and characterized in our laboratory. The average interday relative standard 
deviation was ≤ 9.49%, and the range of accuracy was between 96.1-109% over a concentration 
range of 3.00 to 250. ng/mL with a calculated limit of detection of 1.74 ng/mL. A full 96-well 
plate can be processed and analyzed in 8 h which is five times faster than our previous 96-well 
plate method and only requires 50 µL of serum, plasma, or whole blood. Extensive ruggedness and 
stability studies and matrix comparisons were conducted to create a robust, easily transferrable 
method. As a result, a simple and high-throughput method has been developed and validated for 
the quantitation of sulfur mustard blood protein adducts in low volume blood specimens which 
should be readily adaptable for quantifying human exposures to other alkylating agents.
Introduction
Sulfur mustard, bis(2-chloroethyl)sulfide, is a vesicant and alkylating agent that has been 
developed as a chemical weapon (CW).1 The Chemical Weapons Convention classifies 
* Corresponding author information: WLX3@cdc.gov; phone (770) 488-0393; fax (770) 488-7518. 
Supporting Information
"This information is available free of charge via the Internet at http://pubs.acs.org/."
Disclaimer
The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for 
Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the Centers for 
Disease Control and Prevention, the Public Health Service, or the US Department of Health and Human Services.
HHS Public Access
Author manuscript
Chem Res Toxicol. Author manuscript; available in PMC 2016 April 19.
Published in final edited form as:













sulfur mustard as a Schedule 1 toxic chemical and prohibits its development, fabrication, 
stockpiling, and use.2 The development of reliable methods for long-term detection of sulfur 
mustard exposure in clinical specimens is critical for monitoring accidental exposures during 
demilitarization activities and providing forensic evidence during a suspected chemical 
weapon release.
Sulfur mustard received the reputation “King of battle gases” during World War I as it was 
responsible for approximately 80% of all chemical causalities.3 Despite the Geneva Protocol 
of 1925 which banned its use, sulfur mustard was allegedly used as a CW in the mid-1930s 
in Ethiopia,4 the 1960s in Yemen,4 and the 1980s by Iraq during the Iran-Iraq conflict where 
it caused an estimated 40-50,000 casualties.5-7 Sulfur mustard continues to be a concern due 
to its history of implementation and the continued existence of legacy stockpiles and 
munitions disposed of at sea. Recently, unintentional exposures have occurred domestically 
during demilitarization of a sulfur mustard munition found in a clamshell driveway in 
Delaware,8-10 and by unsuspecting clam fishermen who accidentally dredged chemical 
ordnance.11
Sulfur mustard is an alkylating agent which quickly reacts with nucleophiles such as DNA, 
RNA, water, lipids, peptides, and proteins via an episulfonium ion intermediate.12, 13 Sulfur 
mustard primarily targets the eyes, skin, and lungs.14 As a result, exposed individuals 
typically experience symptoms ranging from nausea, vomiting, and blistering of the skin to 
respiratory disorders or death in extreme cases.3 Exposures in the past have been diagnosed 
using DNA adducts and urinary metabolites as biomarkers.8, 9, 15, 16 Sulfur mustard can bind 
to DNA at several locations, including but not limited to the N7 and O6 position of Gua, and 
the N3 position of Ade, all of which can be measured via immunoassays or mass 
spectrometry.16, 17 DNA adducts are quickly repaired, or DNA synthesis is blocked to avoid 
further replication of the mutation.3 Urinary metabolites, such as thiodiglycol and 1,1′-
sulfonylbis[2-(methylthio)ethane], have also been used to detect exposures in the past. Urine 
metabolites of sulfur mustard are useful biomarkers due to their abundance and non-invasive 
specimen collection methods.18, 19 However, these biomarkers are only present in the body 
up to two weeks post-exposure, limiting their usefulness for long-term examination of 
samples.20
Adducts to blood proteins are a potential tool for assessing exposure once urinary 
metabolites are no longer detectable. Sulfur mustard forms adducts to hemoglobin at Val, 
Glu, and His residues which can be present for up to 120 days.21 However, hemoglobin is 
not commonly used as a biomarker due to the intrinsic sensitivity of these adducts to acids/
bases and instability during mass spectrometry analysis.22 Sulfur mustard can also form 
stable adducts to human serum albumin (HSA) at its reactive Cys-34 residue which has 
made HSA a useful tool for long-term detection of exposure despite the shorter half-life of 
20-25 days.13
A method to quantify sulfur mustard-HSA adducts was originally developed by The 
Netherlands Organisation for Applied Scientific Research (TNO; Rijswijk, The 
Netherlands)23 and further modified by Andacht et al.24 Sulfur mustard binds to the single 
reactive Cys residue (Cys-34) of HSA producing the stable sulfur-hydroxyethylthioethyl [S-
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HETE] adduct. When HSA is digested with pronase, a tripeptide is observed ([S-HETE]-
Cys-Pro-Phe) and can be quantified via LC-MS/MS. The previously reported method was a 
labor intensive process which precipitated blood proteins using trichloroacetic acid and then 
enriched HSA using Cibacron blue affinity. The HSA enriched samples were then digested 
with pronase, filtered, and concentrated using solid phase extraction (SPE) prior to LC-
MS/MS analysis.24 The concentration of [S-HETE]-Cys-Pro-Phe in unknown samples was 
then calculated from a calibration curve comprised of known sulfur mustard spikes into 
blank plasma.
Here we report a straightforward and simplified method for measuring sulfur mustard 
adducts to HSA in human blood specimens. A 96-well plate can be prepared in 3.5 h and 
analyzed via isotope dilution UHPLC-MS/MS in 4.5 h, totaling 8 h from start to finish, 
which is five times faster than previous methods.24 Required sample volume has also 
decreased four-fold while maintaining sensitivity using proteinase K to generate the [S-
HETE]-Cys-Pro-Phe biomarker. The presented method quantifies exposure using a synthetic 
peptide calibration curve as opposed to a calibration curve based on sulfur mustard spiked 
into matrix at different concentrations. Ruggedness, stability, and matrix effect experiments 
were performed, and as a result, a sensitive, high-throughput analytical method for assessing 
sulfur mustard exposure via measurement of protein adducts in human blood specimens has 
been developed and validated. Since the method does not selectively enrich albumin, it 
should be readily adaptable for measuring exposure to other alkylating agents.
Experimental Procedures
Reagents and Materials
HPLC-grade methanol, ammonium bicarbonate, Optima™ acetone, heat sealing foil, 96-
well deep well plates (Fisher Scientific; Hanover, IL); Optima™ LC/MS-grade formic acid 
(Sigma-Aldrich; St. Louis, MO); proteinase K isolated from Tritirachium album (Millipore; 
Billerica, MA); HPLC-grade water and acetonitrile (Tedia; Fairfield, OH); 96-well PCR 
plates and adhesive PCR foil (Eppendorf; Hauppauge, NY); Kinetex C18 column (2.1 x 50 
mm, 1.3 µm) (Phenomenex; Torrance, CA); Oasis Hydrophilic/Lipophilic Balanced (HLB) 
96-well (30 mg) SPE plates (Waters; Milford, MA); Environmental Protection Agency ultra-
dilute sulfur mustard (10 µg/mL) reference standard in isopropanol (Lawrence Livermore 
National Laboratory; Livermore, CA).
Convenience Sample Set
A convenience set from 150 healthy individuals with no known exposure to sulfur mustard 
was purchased from Tennessee Blood Services (Memphis, TN). This convenience set 
contained 50 individual serum, plasma, and blood specimens to evaluate potential 
interferences. As this study used de-identified specimens acquired from commercial sources, 
the work did not meet the definition of human subjects research as specified in 45 CFR 
46.102 (f).
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Calibrators and Quality Controls
Native and d8-isotopically labeled [S-HETE]-Cys-Pro-Phe synthetic peptides were 
synthesized by TNO (Figure 1). The peptides were purified using HPLC and verified to be > 
90% pure using HPLC-UV. The eight-point calibration curve (3.00, 6.00, 12.5, 25.0, 50.0, 
100., 200. and 250. ng/mL) was prepared in 0.1% formic acid in HPLC-grade water, 
aliquoted, and stored at −70°C until use. A 35.0 ng/mL stock solution of d8-isotopically 
labeled peptide in 0.1% formic acid in HPLC-grade water was aliquoted and stored at 
−70°C.
Quality control (QC) materials were made from a stock solution of plasma spiked with 
sulfur mustard by TNO. In summary, pooled plasma was spiked to a final concentration of 
100 µM sulfur mustard (> 98% pure) in acetonitrile and incubated at 37°C for 6 h. The 100 
µM sulfur mustard spiked plasma stock was analyzed by TNO for residual sulfur mustard 
using GC/MS before shipment to the Centers for Disease Control and Prevention. Three QC 
materials, QC Low (QCL), QC Mid (QCM) and QC high (QCH), were prepared by diluting 
the 100 µM sulfur mustard plasma stock with pooled plasma from Tennessee Blood Services 
which were then aliquoted and stored at −70°C. The matrix blank sample was pooled serum 
from Bioreclamation (Westbury, NY). Each QC level was characterized as part of the 
method validation using 22 analytical runs.
Safety Considerations
The analysis of sulfur mustard adducts to Cys-Pro-Phe are not expected to pose a risk 
greater than general peptide analyses. Universal precautions, including the use of proper 
personal protection equipment and biological safety cabinets, were used by trained 
personnel when handling clinical specimens. Plasma and serum pools were screened by the 
vendors, in accordance with FDA regulations, to be free of Hepatitis B, Hepatitis C, 
Treponema Pallidum (Syphilis), and HIV.
Sample Preparation
Matrix blank samples for the calibration curve, QC materials, and any possible clinical 
samples were thawed and centrifuged at 3,000 x g for 5 min to remove particulates. Fifty 
microliters of each QC, matrix blank, and unknown sample were transferred without 
disturbing the pellet to a 96-well deep well plate. Acetone (300 µL) was added to each well 
containing sample to precipitate all proteins present. The sample plate was covered with 
adhesive foil, shaken at 500 rpm for 30 s using a MixMate® (Eppendorf; Hauppauge, NY), 
and centrifuged at 3,000 x g for 5 min at 20°C. The supernatant was removed without 
disturbing the protein pellet, and the pellet was then air dried at room temperature.
Internal standard (20 µL) was added to each well containing sample. Each calibrator (50 µL) 
was added to the wells containing the pellet formed by the matrix blank samples to construct 
an eight-point calibration curve in matrix. Fifty microliters of 0.1% formic acid in HPLC-
grade water was added to the remaining wells including QCs and unknowns to ensure 
homogeneity. An aliquot of 400 µL 50 mM ammonium bicarbonate (pH 7.8) and 100 µL of 
10 mg/mL proteinase K in 50 mM ammonium bicarbonate was added to all wells. The plate 
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was covered with adhesive foil and shaken at 1,000 rpm for 90 min at 50°C on a 
Thermomixer R® (Eppendorf; Hauppauge, NY) for sample digestion.
After digestion, an Oasis HLB SPE plate was conditioned with 1 mL methanol followed by 
1 mL HPLC-grade water on a vacuum manifold. The entire digested sample was loaded onto 
the SPE plate and drawn through the bed using the vacuum manifold. The wells were 
washed with 1 mL 20% methanol in HPLC-grade water and eluted into a new 96-well deep 
well plate with 500 µL acetonitrile. The samples were dried under nitrogen pressure (50 psi) 
at 70°C, reconstituted in 50 µL 0.1% formic acid in HPLC-grade water, transferred to a 96-
well PCR plate, and heat sealed with pierceable foil.
UHPLC-LC/MS
The [S-HETE]-Cys-Pro-Phe analyte was analyzed on an AB Sciex 6500 triple quadruple 
mass spectrometer (Framingham, MA) interfaced with an Agilent 1290 Infinity series 
UHPLC (Santa Clara, CA). Data was collected with Analyst 1.6.2 (AB Sciex) using 
selective reaction monitoring (SRM) with a dwell time of 25 ms for each of the three 
transitions (Table 1). The TurboIonSpray source was operated in positive ion mode and 
under the following parameters: curtain gas= 12 psi; collision gas= 10 psi; ionspray voltage= 
4000 V; temperature= 600°C; gas source 1= 85 psi; and gas source 2= 90 psi. The collision 
energy and declustering, entrance, and collision cell exit potentials were independently 
optimized for quantitation ion, confirmation ion and internal standard and are reported in 
Table 1. The fragmentation patterns of these peptides have been previously reported.24 The 
peptide extract (5 µL) was separated by reversed-phase chromatography using a Kinetex C18 
analytical column heated to 70°C. Mobile phases were 0.1% formic acid in HPLC-grade 
water (mobile phase A) and 0.1% formic acid in acetonitrile (mobile phase B). A linear 
gradient with a flow rate of 350 µL/min was run up to 21.5% mobile phase B over 1.8 min, 
followed by a step to 80% mobile phase B held for 0.2 min, then an immediate return to 2% 
mobile phase B for column equilibration. The total run time was 3.0 min per sample. The 
segmented gradient yielded elution times of 2.0 min (± 0.2 min) for the [S-HETE]-Cys-Pro-
Phe analyte. Extracted ion chromatograms were assessed using Analyst 1.6.2 for correct 
analyte retention time and peak shape.
Method Validation
Data from 22 analytical runs was evaluated to determine intra- and interday accuracy and 
precision (relative standard deviation, %RSD), and linearity for all calibrators and QCs and 
ruggedness, stability, recovery, and matrix effects experiments were performed as part of the 
validation process. Each analytical run contained an eight-point calibration curve in matrix 
blank, three QCs (QCL, QCM, and QCH), and a matrix blank sample. A maximum of two 
runs were prepared and analyzed per day over the span of four weeks by four analysts.
Results and Discussion
A new approach to monitor sulfur mustard adducts to blood proteins without specifically 
enriching for the protein such as HSA was developed to increase analyte recovery while 
increasing throughput. Previous sulfur mustard adduct methods isolated HSA using 
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Cibacron blue prior to enzymatic digestion.24 The disadvantages of enriching for HSA are 
that the process is laborious, time-consuming, costly, and not completely specific for the 
target protein. The currently reported method non-specifically captures proteins in a sample 
and theoretically could be expanded to measure adducts on any Cys that is reactive.
In previous sulfur mustard protein adduct methods, pronase (synonyms: pronase E, actinase 
E, or protease type XIV from Streptomyces griseus) was used to generate the [S-HETE]-
Cys-Pro-Phe peptide.23, 24 However, commercially available pronase is comprised of a 
mixture of proteases resulting in significant variability between different lots and vendors of 
enzyme. During our own digestion studies, pronase cleaved proteins to form the tripeptide 
adduct but would also further digest to form the dipeptide [S-HETE]-Cys-Pro over time. The 
ratio between the dipeptide and tripeptide was found to be highly variable; therefore, a more 
reproducible digestion enzyme was desired to improve method robustness and 
transferability. Alternate enzymes including chymotrypsin, trypsin, and proteinase K were 
investigated. Chymotrypsin yielded a specific six amino acid peptide, Leu-Gln-Gln-Cys-Pro-
Phe, containing the HETE adduct, but was not pursued due to the high cost of chymotrypsin 
and labor intensive process which required reducing and alkylating the sample prior to 
digestion. Trypsin yielded a 21 amino acid peptide containing the HETE adduct but also 
required reducing and alkylating the sample. Despite not typically being considered a 
proteomics grade enzyme, proteinase K was selected since it reliably produced the [S-
HETE]-Cys-Pro-Phe tripeptide, was affordable, and could be used with a simple digestion 
protocol.
To further improve robustness, proteinase K digestion was rigorously tested and optimized. 
Conditions such as digestion time and temperature, enzyme concentration, enzyme buffer 
(i.e. ammonium bicarbonate) concentration, and pH were separately assessed against the 
validated conditions using the QCs at values ± 20% of the final conditions to determine 
ruggedness. The three QC materials were run in triplicate under each test condition. All 
parameters had insignificant influence on the adducted tripeptide when varied ± 20% except 
for a digestion temperature of +20% of the characterized value which yielded greater analyte 
levels.
To further explore the effects of temperature on proteinase K and to ensure reliable 
production of the [S-HETE]-Cys-Pro-Phe peptide, several lots of proteinase K were 
investigated at various temperatures. In brief, five different lots of proteinase K that had been 
used during method characterization were used to digest QCM material at 40°C, 50°C, 
60°C, and 70°C, each run in triplicate and analyzed in one day (Table 2). The digestion 
temperature of 60°C yielded higher signal but also increased %RSD above the characterized 
limits. In addition, proteinase K has been previously reported to become unstable at 
temperatures > 60°C.25 This method is intended to be transferred to other laboratories; 
therefore, it is essential to operate under stable conditions to ensure interoperability.
SPE optimization was conducted to improve method performance. SPE recovery was 
determined by spiking a low level [S-HETE]-Cys-Pro-Phe peptide (12.5 ng/mL) into matrix 
blank samples pre- and post-SPE. Internal standard was added prior to transferring the 
sample to a 96-well PCR plate at the end of the method to normalize for any instrumental 
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variations. The recovery from the HLB SPE was 53 (± 4.1%) with no significant loss from 
the dry down process. Several experiments were conducted to improve recovery including 
exchanging SPE plates and wash volumes and conditions; however, HLB yielded the highest 
recovery.
The eight-point calibration curve was spiked into water, serum, plasma, and whole blood and 
run in triplicate to evaluate matrix effects. The response, which was calculated using the area 
of the analyte over the area of internal standard, was plotted against the peptide 
concentration. All calibration curves were linear and had slopes within 5% of each other.
Statistical analysis of the 22 analytical runs was conducted to validate the method. The 
linear range for [S-HETE]-Cys-Pro-Phe was 3.00-250. ng/mL with an average coefficient of 
determination value of >0.99 and an average line equation of y = 0.054x − 0.0052 with 
%RSD <10% for slope and y-intercept. The limit of detection (LOD) was determined using 
the Taylor method26 in which the four lowest calibrators (3.00, 6.00, 12.5 and 25.0 ng/mL) 
were analyzed for SD and plotted against their respective concentration. The LOD was 
calculated as three times the y-intercept and was determined to be 1.74 ng/mL. The lowest 
calibrator (3.00 ng/mL) is the lowest reportable limit (LRL); results are not reported below 
the LRL. As shown in Figure 2, a sulfur mustard spiked plasma sample (100 nM) was 
compared to this reported method’s lowest calibrator (3.00 ng/mL or 6.3 nM [S-HETE]-Cys-
Pro-Phe) and matrix blank. As expected, the lowest calibrator peak is clearly distinguishable 
from the matrix blank sample. The average ion ratio for the calibration curve (peak area of 
confirmation ion divided by the peak area of the quantitation ion) of 0.47 (± 0.083) was used 
to confirm detection. Accuracy from the 22 analytical runs was determined by dividing the 
average of the calculated concentration for each calibrator by the expected concentration. 
Relative standard deviation was established by dividing the SD of each calibrator by the 
average calculated concentration of the same calibrator. The average calculated 
concentration, SD, accuracy, and %RSD from the validation is shown in Table 3.
Intraday accuracy and %RSD of the calibrators were established as part of the validation. 
Four calibrator levels (6.00, 25.0, 100., and 250. ng/mL) were spiked into matrix blank and 
analyzed independently (n=5) to determine %RSD and accuracy (Table 3). The intraday 
relative standard deviation was ≤ 5.08%, and the range of accuracy was between 92.7-102% 
with a coefficient of determination value of > 0.998.
The QC materials were characterized using the modified Westguard rules.27, 28 Using these 
parameters, a QC was excluded if it fell outside three SDs of the confidence interval or if 
two consecutive QC results fell outside the two SD confidence interval. Interday %RSD was 
established over 22 analytical runs (Table 4). The intraday %RSD of the QC material was 
8.6, 8.1 and 10.1% for QCL, QCM and QCH, respectively. To calculate %RSD, five 
individual preparations of each QC material were simultaneously prepared. The average 
standard deviation from the five individual preparations was divided by the average 
calculated concentration from the same five QCs to calculate %RSD.
Peptide calibrator and QC sample storage temperatures and freeze/thaw stability were 
evaluated. Peptides and QC materials were stored at −70°C, −20°C, 4°C, room temperature, 
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and 37°C and analyzed weekly for four weeks. Peptide solutions were not stable at ≥ 4°C for 
one week and at ≥ −20°C for three weeks, but were stable at −70°C for at least 4 weeks. As 
a result, all peptides were stored at −70°C and monitored for change in concentration via QC 
values (Figure 3). Both native and isotopically labeled peptides were subjected to freeze/
thaw cycles ranging from −70°C to room temperature. The peptides were stable for two 
freeze/thaw cycles. The stability of the QC materials was analyzed in a similar fashion and 
was stable for at least four weeks when stored at room temperature or colder. QC materials 
were subjected to five freeze/thaw cycles ranging from −70°C to room temperature and 
found to be stable.
To measure background levels of sulfur mustard and to monitor for interferences, a 
convenience set of 150 individual samples was analyzed. The convenience set from 
Tennessee Blood Services (Memphis, TN) was comprised of 50 blood, serum, and plasma 
specimens from 150 presumably unexposed individuals. Results showed that all 150 samples 
were negative for [S-HETE]-Cys-Pro-Phe and no interferences were present. QCs served as 
positive controls in lieu of clinical specimens from sulfur mustard exposed individuals which 
were not readily available for analysis.
Binding recovery of sulfur mustard-spiked materials was determined by spiking agent into 
serum, plasma, and blood. A solution of sulfur mustard (> 98% pure) in isopropanol (10 
µg/mL) was spiked into serum, plasma, and blood at three levels (0, 35 and 70 ng/mL), 
incubated at 37°C for 6 h and immediately analyzed using the reported method. As a result, 
the percent recovery between expected and actual calculated concentration for the analyte 
[S-HETE]-Cys-Pro-Phe was 41 (± 1.1%) for serum and plasma and 8.4 (± 0.6%) for whole 
blood. The discrepancy between serum/plasma and blood can be caused by sulfur mustard 
binding to DNA or alternate blood proteins such as hemoglobin. Overall, low yield of 
cysteine adducts can be contributed to hydrolysis of sulfur mustard29 or binding to alternate 
proteins.21
Conclusion
We developed a simplified high-throughput method to quantify sulfur mustard adducts to 
HSA in clinical blood specimens via isotope dilution UHPLC-MS/MS. Sample preparation 
time was significantly reduced by measuring cysteine adducts to hydroxyethylthioethyl in 
total protein rather than isolating adducts following HSA enrichment. Thorough digestion 
studies ensured that [S-HETE]-Cys-Pro-Phe was reliably produced by proteinase K, 
significantly improving the robustness of this approach over previously reported methods. In 
addition, SPE recovery was investigated to improve method performance. Upon 
optimization, the method was validation using 22 analytical runs to evaluate accuracy, 
%RSD, linearity, stability, and matrix effects. Using serum, plasma, and blood from 150 
presumably unexposed individuals, we verified that no background levels of sulfur mustard 
or interfering chromatographic peaks were present. Binding recovery of sulfur mustard was 
investigated by spiking sulfur mustard into serum, plasma, and whole blood and measuring 
the tripeptide biomarker, [S-HETE]-Cys-Pro-Phe. Recovery of spiked agent was 41% for 
serum and plasma and 8.4% for whole blood. As a result of these efforts, the reported 
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method can measure sulfur mustard exposure via the hydroxyethylthioethyl adduct to HSA 
in low volume clinical blood matrix specimens in 8 hours.
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The chemical structures of (A) native and (B) d8-isotopically labeled [S-HETE]-Cys-Pro-
Phe peptide. The fragmentation sites for the quantitation and confirmation transitions are 
shown with dashed lines.
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Chromatograph comparing sulfur mustard spiked into plasma (100 nM) (red line), lowest [S-
HETE]-Cys Pro-Phe peptide calibrator of 6.30 nM (3.00 ng/mL) (blue line), and matrix 
blank sample (black line).
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4-week stability of QCL when stored at −70°C. SD, standard deviation; QCL, quality 
control low.
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Table 1



















Quantition Ion [S-HETE]-Cys-Pro-Phe 470.2 105.1 60 2.0 29 7.0
Confirmation Ion [S-HETE]-Cys-Pro-Phe 470.2 137.1 60 7.0 28 11
Internal Standard d8-[S-HETE]-Cys-Pro-Phe 478.2 113.1 60 11 27 7.0
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Table 2
Effects of digestion temperature on the formation of [S-HETE]-Cys-Pro-Phe from QCM material using five 




(± SD) (ng/mL) %RSD
40°C 36.8 (± 5.40) 14.7%
50°C 40.5 (± 5.05) 12.5%
60°C 64.5 (± 17.4) 27.0%
70°C 44.1 (± 24.5) 55.6%
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Table 3
Calculated interday and intraday concentration, accuracy, and relative standard deviation for the [S-HETE]-
Cys-Pro-Phe peptide calibrators.

















3.00 3.28 (± 0.310) 109 9.49 -- -- --
6.00 5.77 (± 0.380) 96.1 6.66 5.56 (± 0.280) 92.7 5.08
12.5 12.3 (± 0.840) 98.7 6.78 -- -- --
25.0 24.5 (± 1.34) 98.1 5.46 24.4 (± 0.590) 97.4 2.40
50.0 48.3 (± 2.40) 96.6 4.96 -- -- --
100. 100. (± 4.03) 100. 4.02 99.8 (± 4.41) 102. 4.68
200. 202. (± 6.89) 101 3.41 -- -- --
250. 250. (± 9.82) 100. 3.93 242. (± 10.4) 97.7 4.18
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Table 4
Interday relative standard deviation of the sulfur mustard protein adduct QC materials (n=22) over four weeks. 







QCL 9.05 (± 1.62) 17.9
QCM 36.7 (± 5.00) 13.6
QCH 76.9 (± 9.20) 12.0
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